tiprankstipranks
X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR
US Market

X4 Pharmaceuticals (XFOR) Income Statement

Compare
966 Followers

X4 Pharmaceuticals Income Statement

Last quarter (Q3 2024), X4 Pharmaceuticals's total revenue was $560.00K, an increase of Infinity% from the same quarter last year. In Q3, X4 Pharmaceuticals's net income was $-36.70M. See X4 Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 3.00M$ 0.00
Gross Profit
$ -2.00M$ -1.99M$ -1.89M$ 3.00M$ -672.00K
Operating Expenses
$ 107.52M$ 88.08M$ 75.35M$ 62.87M$ 47.80M
Depreciation and Amortization
$ 419.00K$ 1.99M$ 1.89M$ 1.23M$ 672.00K
EBITDA
$ -107.10M$ -87.57M$ -85.11M$ -58.06M$ -51.70M
Operating Income
$ -107.52M$ -87.57M$ -85.11M$ -59.87M$ -51.70M
Other Income/Expenses
$ 6.43M$ -6.27M$ -3.57M$ -2.11M$ -1.10M
Pretax Income
$ -101.09M$ -93.84M$ -88.68M$ -61.98M$ -52.81M
Net Income
$ -101.17M$ -93.87M$ -88.70M$ -62.13M$ -56.60M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.57$ -1.48$ -3.44$ -3.09$ -4.91
Diluted EPS
$ -0.57$ -1.48$ -3.44$ -3.09$ -4.91
Weighted Average Shares Outstanding
177.81M 63.53M 25.75M 20.08M 11.53M
Weighted Average Shares Outstanding (Diluted)
177.81M 63.53M 25.75M 20.08M 11.53M
Currency in USD

X4 Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis